Navigation
Home
Advocating for Access
Background
Letters for Access
Press Releases For Access
Simplified Community Materials
Simplified Community Materials
Understanding your HCV infection
Community Led Reports
Country Information
Indonesia
India
Vietnam
Generic DAAs Pricing
Resources
Guidelines
Key Research Publication
Other Important Documents and Reports
News
Gallery
Photos
Video
Stories
Updated WHO screening, care and treatment of persons with hepatitis C infection_ April 2016.
Updated WHO screening, care and treatment of persons with hepatitis C infection_ April 2016.
Download PDF
April 18, 2016
/
News
Related
Posts
Patient Groups and CSOs in Asia written a letter to Indian Government to Request Waiver on Local Clinical Trial for The Coming Generic DAAs
Hepatitis C Treatment Snapshots: ledipasvir and sofosbuvir co-formulation
BMS’ patent bid for Hep C treatment Daclatasvir Challenged
Response from CEO, CHAI about the Quick Start program in November 2016
Flawed patents on hepatitis C drugs latest to be challenged in global push for access
Glecaprevir-Pibrentasvir Effective for Hepatitis C After Treatment Failure
Simplified HCV Treatment* for Treatment-Naive Patients Without Cirrhosis
Letter from Asian community and treatment advocates to Chief Executive Officer of CHAI regarding the Quick start program and concerns that patients would have to pay for sofosbuvir and diagnostics to be a part of the program in October 2016
